KALA BIO, Inc. (KALA)

KALA BIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.22	51.18	50.9	70.5	92.14	77.26
Short-Term Investments	-	-	-	-	0.91	76.88
Cash & Short-Term Investments	42.22	51.18	50.9	70.5	93.05	154.15
Cash Growth	-12.90%	0.56%	-27.80%	-24.24%	-39.64%	78.93%
Accounts Receivable	-	-	-	0.2	15.35	9.6
Other Receivables	-	-	-	0.91	2.11	0.25
Receivables	-	-	-	1.1	17.46	9.85
Inventory	-	-	-	-	8.64	5.23
Prepaid Expenses	3.5	1.62	1.98	0.7	1.31	1.2
Restricted Cash	-	-	-	-	2.04	-
Other Current Assets	-	-	-	13.65	1.88	0.95
Total Current Assets	45.72	52.8	52.87	85.94	124.37	171.38
Property, Plant & Equipment	2.3	2.44	2.78	0.42	4.02	31.02
Other Long-Term Assets	0.24	0.25	0.3	0.46	11.04	19.21
Total Assets	48.25	55.48	55.95	86.82	139.43	221.61
Accounts Payable	0.93	0.63	0.92	2.83	4.9	1.72
Accrued Expenses	4.04	4.63	4.36	5.86	10.69	13.75
Current Portion of Long-Term Debt	15.5	10.34	-	5	-	-
Current Portion of Leases	0.39	0.38	0.33	0.01	0.71	1.53
Current Unearned Revenue	0.55	0.99	2.73	0.81	10.3	5.22
Other Current Liabilities	1.56	-	-	11.17	10.83	-
Total Current Liabilities	22.98	16.96	8.35	25.69	37.42	22.23
Long-Term Debt	15.12	20.1	34.19	37.94	78.93	72.24
Long-Term Leases	1.33	1.43	1.8	-	0.55	27.14
Other Long-Term Liabilities	3.12	4.66	4.11	4.22	5.72	-
Total Liabilities	42.54	43.15	48.45	67.85	122.62	121.61
Common Stock	0.01	0.01	0	0	0	0.06
Additional Paid-In Capital	682.57	680.25	636.91	606.18	559.19	499.72
Retained Earnings	-676.87	-667.92	-629.41	-587.21	-542.39	-399.78
Comprehensive Income & Other	-	-	-	-	-	0
Total Common Equity	5.71	12.33	7.5	18.97	16.8	100
Shareholders' Equity	5.71	12.33	7.5	18.97	16.8	100
Total Liabilities & Equity	48.25	55.48	55.95	86.82	139.43	221.61
Total Debt	32.35	32.25	36.32	42.95	80.19	100.92
Net Cash (Debt)	9.87	18.93	14.57	27.55	12.86	53.23
Net Cash Growth	-17.14%	29.90%	-47.10%	114.21%	-75.84%	-
Net Cash Per Share	2.11	4.99	5.99	18.11	9.77	50.81
Filing Date Shares Outstanding	6.45	6.45	2.82	2.03	1.45	1.23
Total Common Shares Outstanding	6.45	6.09	2.76	1.71	1.31	1.18
Working Capital	22.74	35.84	44.52	60.26	86.94	149.15
Book Value Per Share	0.88	2.02	2.72	11.12	12.83	84.86
Tangible Book Value	5.71	12.33	7.5	18.97	16.8	100
Tangible Book Value Per Share	0.88	2.02	2.72	11.12	12.83	84.86
Machinery	-	2.06	1.76	1.62	3.87	4.9
Construction In Progress	-	-	0.1	-	1.72	1.33
Leasehold Improvements	-	-	-	-	-	0.36

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q